Milestone Scientific (MLSS) Cash & Equivalents (2010 - 2026)

Milestone Scientific (MLSS) has 17 years of Cash & Equivalents data on file, last reported at $250000.0 in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents fell 88.87% year-over-year to $250000.0; the trailing twelve-month figure through Mar 2026 stood at $250000.0 (down 88.87% YoY), and the FY2025 full-year result was $1.1 million, down 65.85% from the prior year.
• Cash & Equivalents slipped to $250000.0 in Q1 2026, from $1.1 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $13.3 million in Q1 2022 to a low of $250000.0 in Q1 2026.
• A 5-year average of $4.6 million and a median of $3.3 million in 2024 frame the typical range for Cash & Equivalents.
• Across the five-year window, Cash & Equivalents jumped 120.01% in 2024 and slumped 88.87% in 2026, its largest moves.
• Tracing MLSS's Cash & Equivalents over 5 years: stood at $8.7 million in 2022, then slumped by 65.83% to $3.0 million in 2023, then climbed by 9.41% to $3.3 million in 2024, then tumbled by 65.85% to $1.1 million in 2025, then slumped by 77.53% to $250000.0 in 2026.
• Business Quant data shows MLSS's Cash & Equivalents at $250000.0 in Q1 2026, $1.1 million in Q4 2025, and $1.3 million in Q3 2025.